Certified Diabetes Care and Education Specialist (CDCES) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Prepare for the Certified Diabetes Care and Education Specialist Test. Utilize flashcards, multiple choice questions with hints, and detailed explanations. Get exam-ready!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.

In managing diabetes, what is a primary characteristic of GLP-1 mimetics?

Stimulating glucagon secretion
Enhancing gastric emptying
Increasing insulin sensitivity
Promoting feelings of fullness

The correct answer is: Promoting feelings of fullness

GLP-1 mimetics are a class of medications used in the management of type 2 diabetes, and a key characteristic of these drugs is their ability to promote feelings of fullness, or satiety. These medications mimic the action of glucagon-like peptide-1 (GLP-1), a hormone that is released in response to food intake. By activating GLP-1 receptors, these drugs not only help regulate blood sugar levels but also slow gastric emptying and enhance the sensation of fullness, which can lead to reduced caloric intake and weight loss. This property is particularly beneficial for individuals with type 2 diabetes, many of whom may struggle with obesity. By promoting satiety and potentially decreasing appetite, GLP-1 mimetics help to manage both blood glucose levels and body weight, addressing two critical aspects of diabetes care. In contrast, while GLP-1 mimetics have effects on gastric emptying, insulin secretion, and even glucagon levels to some degree, the primary characteristic that stands out among these options is their role in enhancing feelings of fullness. This makes option D the most fitting choice in the context of diabetes management with GLP-1 mimetics.